يعرض 1 - 8 نتائج من 8 نتيجة بحث عن '"Femoral closure"', وقت الاستعلام: 0.75s تنقيح النتائج
  1. 1
    دورية أكاديمية
  2. 2
  3. 3
    دورية أكاديمية
  4. 4
  5. 5
    دورية أكاديمية

    وصف الملف: application/pdf

    العلاقة: Kaki, Amir; Blank, Nimrod; Alraies, M. Chadi; Kajy, Marvin; Grines, Cindy L.; Hasan, Reema; Htun, Wah Wah; Glazier, James; Mohamad, Tamam; Elder, Mahir; Schreiber, Theodore (2018). "Access and closure management of large bore femoral arterial access." Journal of Interventional Cardiology 31(6): 969-977.; https://hdl.handle.net/2027.42/147180Test; Journal of Interventional Cardiology; Kurra V, Schoenhagen P, Roselli EE, et al. Prevalence of significant peripheral artery disease in patients evaluated for percutaneous aortic valve insertion: preprocedural assessment with multidetector computed tomography. J Thorac Cardiovasc Surg. 2009; 137: 1258 – 1264.; Samal AK, White CJ. Percutaneous management of access site complications. Catheter Cardiovasc Interv. 2002; 57: 12 – 23.; Sanghvi K, Kurian D, Coppola J. Transradial intervention of iliac and superficial femoral artery disease is feasible. J Interv Cardiol. 2008; 21: 385 – 387.; Kiemeneij F, Laarman GJ, Odekerken D, Slagboom T, van der Wieken R. A randomized comparison of percutaneous transluminal coronary angioplasty by the radial, brachial and femoral approaches: the access study. J Am Coll Cardiol. 1997; 29: 1269 – 1275.; Walther T, Simon P, Dewey T, et al. Transapical minimally invasive aortic valve implantation. Circulation. 2007; 116: I‐240 – I‐245.; Coburn MA. A Perspective on Sheath Selection and Access Sites for Coronary Angiography. In. Cath Lab Digest. Vol 18: HMP Cardiovascular; Sep. 2010.; Htyte N, White CJ. Vascular access for percutaneous interventions and angiography. In: Mukherjee D, Bates ER, Roffi M, Moliterno DJ, eds. Cardiovascular Catheterization and Intervention: A Textbook of Coronary, Peripheral, and Structural Heart Disease. 1st ed. London: Informa Healthcare; 2010.; Bauernschmitt R, Schreiber C, Bleiziffer S, et al. Transcatheter aortic valve implantation through the ascending aorta: an alternative option for no‐access patients. Paper presented at: The heart surgery forum, 2009.; Greenbaum AB, O’Neill WW, Paone G, et al. Caval‐aortic access to allow transcatheter aortic valve replacement in otherwise ineligible patients: initial human experience. J Am College Cardiol. 2014; 63: 2795 – 2804.; Abu‐Fadel MS, Sparling JM, Zacharias SJ, et al. Fluoroscopy vs traditional guided femoral arterial access and the use of closure devices: a randomized controlled trial. Catheter Cardiovasc Interv. 2009; 74: 533 – 539.; Fitts J, Ver Lee P, Hofmaster P, Malenka D. Fluoroscopy‐guided femoral artery puncture reduces the risk of PCI‐related vascular complications. J Interv Cardiol. 2008; 21: 273 – 278.; Seto AH, Abu‐Fadel MS, Sparling JM, et al. Real‐time ultrasound guidance facilitates femoral arterial access and reduces vascular complications: fAUST (Femoral Arterial Access With Ultrasound Trial). JACC. 2010; 3: 751 – 758.; Hind D, Calvert N, McWilliams R, et al. Ultrasonic locating devices for central venous cannulation: meta‐analysis. BMJ. 2003; 327: 361.; Ramlawi B, Anaya‐Ayala JE, Reardon MJ. Transcatheter aortic valve replacement (TAVR): access planning and strategies. Methodist DeBakey Cardiovasc J. 2012; 8: 22 – 25.; Martin JL, Pratsos A, Magargee E, et al. A randomized trial comparing compression, perclose proglide™ and Angio‐Seal VIP™ for arterial closure following percutaneous coronary intervention: the cap trial. Catheter Cardiovasc Interv. 2008; 71: 1 – 5.; Dosluoglu HH, Cherr GS, Harris LM, Dryjski ML. Total percutaneous endovascular repair of abdominal aortic aneurysms using Perclose ProGlide closure devices. J Endovasc Ther. 2007; 14: 184 – 188.; Lukasiewicz A. Treatment of acute lower limb ischaemia. Vasa. 2016; 45: 213 – 221.; Toggweiler S. Percutaneous aortic valve replacement: vascular outcomes with a fully percutaneous procedure.; Durand E, Borz B, Godin M, et al. Transfemoral aortic valve replacement with the Edwards SAPIEN and Edwards SAPIEN XT prosthesis using exclusively local anesthesia and fluoroscopic guidance: feasibility and 30‐day outcomes. JACC. 2012; 5: 461 – 467.; Abdul‐Jawad Altisent O, Durand E, Muñoz‐García AJ, et al. Warfarin and antiplatelet therapy versus warfarin alone for treating patients with atrial fibrillation undergoing transcatheter aortic valve replacement. JACC Cardiovasc Interv. 2016; 9: 1706 – 1717.; Resnic FS, Wang TY, Arora N, et al. Quantifying the learning curve in the use of a novel vascular closure device: an analysis of the NCDR (National Cardiovascular Data Registry) CathPCI registry. JACC. 2012; 5: 82 – 89.; Van Mieghem NM, Latib A, van der Heyden J, et al. Percutaneous plug‐based arteriotomy closure device for large‐bore access: a multicenter prospective study. JACC. 2017; 10: 613 – 619.; Lata K, Htun WW, Grines C, Kaki A, Schreiber T. Pre‐close technique of percutaneous closure for delayed hemostasis of large‐bore femoral sheaths. Catheter Cardiovasc Interv. 2016; 87: S165.; Sherev DA, Shaw RE, Brent BN. Angiographic predictors of femoral access site complications: implication for planned percutaneous coronary intervention.; Hamraoui K, Ernst SM, van Dessel PF, et al. Efficacy and safety of percutaneous treatment of iatrogenic femoral artery pseudoaneurysm by biodegradable collagen injection. J Am College Cardiol. 2002; 39: 1297 – 1304.; Hessel SJ, Adams DF, Abrams HL. Complications of angiography. Radiology. 1981; 138: 273 – 281.; Altin R, Flicker S, Naidech H. Pseudoaneurysm and arteriovenous fistula after femoral artery catheterization: association with low femoral punctures. Am J Roentgenol. 1989; 152: 629 – 631.; Ahmad F, Turner S, Torrie P, Gibson M. Iatrogenic femoral artery pseudoaneurysms—a review of current methods of diagnosis and treatment. Clin Radiol. 2008; 63: 1310 – 1316.; Morgan R, Belli A‐M. Current treatment methods for postcatheterization pseudoaneurysms. J Vasc Interv Radiol. 2003; 14: 697 – 710.; Lee MS, Applegate B, Rao SV, Kirtane AJ, Seto A, Stone GW. Minimizing femoral artery access complications during percutaneous coronary intervention: a comprehensive review. Catheter Cardiovasc Interv. 2014; 84: 62 – 69.; Pitta SR, Prasad A, Kumar G, Lennon R, Rihal CS, Holmes DR. Location of femoral artery access and correlation with vascular complications. Catheter Cardiovasc Interv. 2011; 78: 294 – 299.; Radner S. An attempt at the roentgenologic visualization of coronary blood vessels in man. Acta Radiologica. 1945; 26: 497 – 502.; Radner S. Thoracal aortography by catheterization from the radlal artery. Acta Radiologica. 1948; 29: 178 – 180.; Brodén B, Jönsson G, Karnell J. Thoracic aortography: observations on technical problems connected with the method and various risks involved in its use. Acta Radiologica. 1949: 498 – 508.; Webb JG, Chandavimol M, Thompson CR, et al. Percutaneous aortic valve implantation retrograde from the femoral artery. Circulation. 2006; 113: 842 – 850.; Howell M, Villareal R, Krajcer Z. Percutaneous access and closure of femoral artery access sites associated with endoluminal repair of abdominal aortic aneurysms. J Endovasc Ther. 2001; 8: 68 – 74.; Redfors B, Watson BM, McAndrew T, et al. Mortality, length of stay, and cost implications of procedural bleeding after percutaneous interventions using large‐bore catheters. JAMA Cardiol. 2017; 2: 798 – 802.; Harold JG, Bass TA, Bashore TM, et al. ACCF/AHA/SCAI 2013 update of the clinical competence statement on coronary artery interventional procedures. Catheter Cardiovasc Interv. 2013; 82: 2.; Levine GN, Bates ER, Blankenship JC, et al. ACC/AHA/SCAI focused update on primary percutaneous coronary intervention for patients with ST‐elevation myocardial infarction: an update of the 2011 ACCF/AHA/SCAI guideline for percutaneous coronary intervention and the 2013 ACCF/AHA guideline for the management of ST‐elevation myocardial infarction. Circulation. 2015; CIR.0000000000000336.; Archbold RA, Robinson NM, Schilling RJ. Radial artery access for coronary angiography and percutaneous coronary intervention. BMJ. 2004; 329: 443.; O’neill WW, Kleiman NS, Moses J, et al. A prospective randomized clinical trial of hemodynamic support with impella 2.5 TM versus intra‐aortic balloon pump in patients undergoing high‐risk percutaneous coronary intervention: the PROTECT II study. Circulation. 2012; CIRCULATIONAHA. 112.098194.; Werdan K, Gielen S, Ebelt H, Hochman JS. Mechanical circulatory support in cardiogenic shock. Eur Heart J. 2013; 35: 156 – 167.; Pedersen OM, Aslaksen A, Vik‐Mo H. Ultrasound measurement of the luminal diameter of the abdominal aorta and iliac arteries in patients without vascular disease. J Vasc Surg. 1993; 17: 596 – 601.; Pearce WH, Slaughter MS, LeMaire S, et al. Aortic diameter as a function of age, gender, and body surface area. Surgery. 1993; 114: 691 – 697.; Gerhard‐Herman MD, Gornik HL, Barrett C, et al. 2016 AHA/ACC guideline on the management of patients with lower extremity peripheral artery disease: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Circulation. 2017; 135: e686 – e725.; Montalescot G, Sechtem U, Achenbach S, et al. 2013 ESC guidelines on the management of stable coronary artery disease: the task force on the management of stable coronary artery disease of the European Society of Cardiology. Eur Heart J. 2013; 34: 2949 – 3003.; Judkins MP, Gander MP. Prevention of complications of coronary arteriography. Circulation. 1974; 49: 599 – 602.

  6. 6
  7. 7
  8. 8